Brahmapur: In a significant advance in genetic diagnostics, researchers at IISER-Brahmapur have developed a nanotechnology-enabled biosensing platform capable of rapidly and sensitively detecting DNA sequences associated with Turner Syndrome, a rare chromosomal disorder caused by the complete or partial loss of one X chromosome in females. Turner Syndrome affects nearly one in 2,500 female births and is associated with short stature, delayed puberty, infertility, and cardiovascular and renal abnormalities. Published in the internationally acclaimed journal ’Advanced Functional Materials,’ the study demonstrates the potential of the nanoplatform to transform genetic screening by enabling rapid, cost-effective and accessible DNA diagnostics. The researchers believe the technology can be adapted for the detection of other inherited genetic disorders, paving the way for broader applications in precision medicine. While the technology requires further clinical validation before routine medical application, it marks a major step towards next-generation molecular diagnostics and personalised healthcare.